|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
3
|
Zenith Epigenetics
|
Feb 08, 2019 03:26PM
|
|
Re: CD Venture
|
3
|
Resverlogix Corp.
|
May 17, 2016 03:34PM
|
|
Re: CBC Radio News Interview with Dr. Sweeney
|
10
|
Resverlogix Corp.
|
Feb 07, 2022 01:10PM
|
|
Re: Cavendish and Innovation
|
7
|
Resverlogix Corp.
|
Oct 25, 2015 10:50AM
|
|
Re: Cash
|
3
|
Zenith Epigenetics
|
Oct 07, 2019 05:22AM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
8
|
Resverlogix Corp.
|
Jan 08, 2022 12:20PM
|
|
Re: Cases of COVID-19 infection are on the rise again in Brazil.
|
5
|
Resverlogix Corp.
|
Jan 05, 2022 01:38PM
|
|
Re: Cart...
|
4
|
Resverlogix Corp.
|
Jun 03, 2021 12:31PM
|
|
Re: CANTOS and CIRT
|
1
|
Resverlogix Corp.
|
Nov 14, 2017 03:20PM
|
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 14, 2017 06:21PM
|
|
Re: CANTOS and CIRT
|
1
|
Resverlogix Corp.
|
Nov 13, 2017 02:42PM
|
|
Re: CANTOS and CIRT
|
2
|
Resverlogix Corp.
|
Nov 13, 2017 05:15PM
|
|
Re: Can we expect another plea from DM Monday?
|
3
|
Resverlogix Corp.
|
Nov 16, 2019 06:29PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
7
|
Resverlogix Corp.
|
Feb 20, 2022 12:06PM
|
|
Re: Calgary-developed COVID-19 drug begins trials in local hospitals and Brazil.
|
2
|
Resverlogix Corp.
|
Feb 20, 2022 06:26PM
|
|
Re: CALGARY, Alberta, March 02, 2023 - Resverlogix Corp.
|
4
|
Resverlogix Corp.
|
Mar 04, 2023 05:42PM
|
|
Re: By the time….
|
3
|
Resverlogix Corp.
|
Mar 03, 2022 11:50AM
|
|
Re: breaking news...Apple forms secret team to address Diabetes?
|
1
|
Resverlogix Corp.
|
Apr 13, 2017 10:18AM
|
|
Re: Breaking down the Webcast
|
6
|
Resverlogix Corp.
|
Oct 24, 2019 01:36PM
|
|
Re: Breaking down the Webcast
|
4
|
Resverlogix Corp.
|
Oct 08, 2019 10:05PM
|
